Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis
- PMID: 11237195
- DOI: 10.1002/biof.5520130106
Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis
Abstract
Lipid peroxidation is involved in the pathogenesis of chronic diseases including atherosclerosis. Oxidized lipoprotein has diverse biological activities and is believed to initiate atheroma formation and maturate fatty plaque. The active components of oxidized lipoproteins still remain to be clarified, but a likely candidate is the phosphatidylcholine (PC) having an sn-2-short-chain acyl group with a methyl, hydroxyl, aldehydic or carboxylic terminal. These unique PCs, formed by oxidative fragmentation of the polyunsaturated acyl group of the parent PC in liposomes, low density lipoproteins and blood plasma, induce platelet aggregation through the activation of the receptor for platelet-activating factor (PAF), due to their resemblance in structure with PAF. We have found that PAF-like lipids regulate DNA synthesis and production of nitric oxide independently of the activation of the PAF receptor in vascular smooth muscle cells. Regulation of vascular cell function through two distinct signaling pathways mediated by PAF-like lipids provides new insight into the mechanism of induction of atherosclerosis.
Similar articles
-
Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.Lipids. 1996 Dec;31(12):1251-8. doi: 10.1007/BF02587909. Lipids. 1996. PMID: 8972457
-
Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.J Clin Invest. 1995 Nov;96(5):2322-30. doi: 10.1172/JCI118288. J Clin Invest. 1995. PMID: 7593619 Free PMC article.
-
Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.Atheroscler Suppl. 2002 Dec;3(4):57-68. doi: 10.1016/s1567-5688(02)00045-4. Atheroscler Suppl. 2002. PMID: 12573364 Review.
-
Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein.Endothelium. 2006 Jan-Feb;13(1):1-8. doi: 10.1080/10623320600659948. Endothelium. 2006. PMID: 16885061
-
Oxidized LDL contains inflammatory PAF-like phospholipids.Trends Cardiovasc Med. 2001 Apr-May;11(3-4):139-42. doi: 10.1016/s1050-1738(01)00100-1. Trends Cardiovasc Med. 2001. PMID: 11686003 Review.
Cited by
-
Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability.Lipids. 2013 Jun;48(6):569-78. doi: 10.1007/s11745-013-3779-1. Epub 2013 Mar 14. Lipids. 2013. PMID: 23494578 Free PMC article.
-
PC and PE synthesis: mixed micellar analysis of the cholinephosphotransferase and ethanolaminephosphotransferase activities of human choline/ethanolamine phosphotransferase 1 (CEPT1).Lipids. 2002 Jul;37(7):663-72. doi: 10.1007/s11745-002-0947-6. Lipids. 2002. PMID: 12216837
-
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.Toxins (Basel). 2016 Dec 16;8(12):376. doi: 10.3390/toxins8120376. Toxins (Basel). 2016. PMID: 27999257 Free PMC article. Review.
-
Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.Lipids. 2004 Feb;39(2):97-109. doi: 10.1007/s11745-004-1207-5. Lipids. 2004. PMID: 15134136
-
Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.Mediators Inflamm. 2003 Aug;12(4):221-7. doi: 10.1080/09629350310001599666. Mediators Inflamm. 2003. PMID: 14514473 Free PMC article.